Pure Global AI
NCT05967026Enrolling by invitation

Characterization of Myocardial Infarction Scar Using Magnetic Resonance Imaging

Central Hospital, Nancy, FranceClinicalTrials.gov
Verified
Study focus
Disease/Condition
Myocardial Infarction
Study type
Observational
Sponsor & location
Primary sponsor
Central Hospital, Nancy, France
Location
Nancy, France
Timeline & enrollment
Phase
N/A
Start date
Jul 01, 2023
End date
Aug 01, 2023
Enrollment
150 participants
Primary outcome

Intramural scar surface in cm²

Summary

The goal of this monocentric observationnal study is to describe the characteristics of the
 myocardial infarction scar in terms of transmurality in residual LVEF35% patients.
 
 The primary objective is to determine the frequency of the criterion intramural scar
 ≥1.47cm2 (measured by MRI) in patients who presented with myocardial infarction with
 residual LVEF≥35%.

ICD-10 classifications
Acute myocardial infarctionAcute myocardial infarction, unspecifiedOld myocardial infarctionSubsequent myocardial infarctionObservation for suspected myocardial infarction
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05967026
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05967026 through Pure Global AI's free database. This phase not specified trial is sponsored by Central Hospital, Nancy, France and is currently Enrolling by invitation. The study focuses on Myocardial Infarction. Target enrollment is 150 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.